Innovent Biologics’ IBI311 New Drug Application Accepted for Review by China’s CDE
Innovent Biologics Inc., (HKG: 1801), a leading biopharmaceutical company in China, has announced that the...
Company
Union Hospital Teams Up with Baidu Health for AI-Enhanced Outpatient Services
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, has entered into a...
Zai Lab and Innoviva Win China Approval for SUL-DUR to Treat Hospital-Acquired Pneumonia
Zai Lab Ltd (NASDAQ: ZLAB; HKG: 9688), a China-based biopharmaceutical company, in collaboration with US...
FDA Gives Accelerated Nod to Amgen’s Imdelltra in Small Cell Lung Cancer
The US Food and Drug Administration (FDA) has granted accelerated approval to Amgen (NASDAQ: AMGN)...
Eli Lilly’s Weekly Insulin Efsitora Alfa Matches Daily Basal Insulins in Reducing A1C Levels
Eli Lilly and Company (NYSE: LLY), a global healthcare company, has announced results from a...
Pharmaron to Sell Proteologix Stake in Upcoming Johnson & Johnson Acquisition
Pharmaron Beijing Co., Ltd, a leading Contract Research Organization (CRO) based in Beijing (HKG: 3759;...
Fosun Pharma Nods to Fosun Health Spin-Off; IPO Venue and Requirements Under Review
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196), a leading pharmaceutical company in...
Medtronic’s Advanced Mazor X Spinal Surgery Robot Receives Chinese Market Clearance
Medtronic (NYSE: MDT), the US-Irish medical technology giant, has announced that it has received approval...
Zhejiang Huahai Pharmaceutical Co., Ltd Plans Capital Raise for Digital Manufacturing Expansion
Zhejiang Huahai Pharmaceutical Co., Ltd (SHA: 600521), a leading Chinese pharmaceutical company, has unveiled plans...
Porton Biologics and SAFE Collaborate to Accelerate Pharmaceutical R&D Services
Suzhou Porton Biologics Ltd, a China-based Contract Development and Manufacturing Organization (CDMO), has entered into...
Biotherus Inc. Advances PM8002 Bispecific Antibody to Phase III for Triple Negative Breast Cancer
China’s Biotheus Inc. has announced the initiation of a Phase III clinical study for its...
Jiangsu Hengrui’s Camrelizumab/Apatinib Combo Denied FDA Approval Over Manufacturing Issues
The US Food and Drug Administration (FDA) has issued a complete response letter to Jiangsu...
ImmuneOnco Biopharmaceuticals’ CD47 Inhibitor Receives NMPA Go-Ahead for Phase III Trial
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd has announced that it has received approval from the National...
Siemens Healthineers and Ruijin Hospital Collaborate to Build Medical Digital Human Metaverse
Siemens Healthineers AG, the German medical technology major, has entered into a strategic partnership with...
CSPC Pharmaceutical’s βKlotho Monoclonal Antibody JMT202 Receives Clinical Trial Approval from NMPA
CSPC Pharmaceutical Group Ltd (HKG: 1093), a leading pharmaceutical company based in China, has announced...
Roche’s CT-388 Shows Significant Weight Loss in Phase I Clinical Trial for Obesity
Switzerland-based healthcare giant Roche (SWX: ROG) has announced preliminary results from a Phase I study...
Biocytogen Expands Reach to India with GVSAP Partnership for BioMice Models
A recent stock exchange announcement from China-based Biocytogen (HKG: 2315) has highlighted a strategic partnership...
HutchMed Chairman Simon To Steps Down, Dr. Dan Eldar Appointed Successor
HutchMed (NASDAQ: HCM, HKG: 0013) today announced a significant change in leadership with the long-serving...
Eisai to Support Grassroots Healthcare in China with Significant Pariet Donation
Eisai (TYO: 4523), a leading Japanese pharmaceutical company, has announced its commitment to donate 100,000...
North China Pharmaceutical’s Ormutivimab Approved for Pediatric Use in China
North China Pharmaceutical Group Corporation (SHA: 600812) has announced that it has received approval from...